1 / 11

VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS | Coherent Market Insights

<br>Read here the latest updates on the VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS published by CMI team.<br>

adwaitcoherent
Télécharger la présentation

VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker

  2. VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS Viral Vector and Plasmid DNA Testing Services Market, by Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), by End User (Research Organizations and Pharmaceutical and Biotechnological Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials in the cells. Viral vectors are playing significant role in the pharmaceutical sector, as many research and innovations are ongoing for the development of drugs for treating cancer, cardiovascular diseases, ophthalmology, hematology, and many others. Market players are focusing on partnership to expand their business in the viral vector and plasmid DNA testing services market, which is expected to boost growth of the market over the forecast period. For instance, in November 2019, Harvard University and Massachusetts Institute of Technology entered into a partnership with GE Healthcare Life Sciences, Fujifilm, and five research hospitals, in order to build a research center worth US$ 50 million at Greater Boston, U.S. for developing new cell and gene therapy. The hospitals involved in the partnership include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, and Massachusetts General Hospital.

  4. Figure 1. Global Viral Vector and Plasmid DNA Testing Services Market Value (US$ Mn), by Region, 2018

  5. Inorganic growth strategies such as business expansions adopted by key players is expected to boost growth of the global viral vector and plasmid DNA testing services market. The global viral vector and plasmid DNA testing services market is expected to witness significant growth over the forecast period, owing to business expansions by key players. For instance, in May 2016, Eurofins MWG Operon LLC., a subsidary of Eurofins Scientific Company, announced to open a new DNA sequencing Lab in Toronto, Canada, in order to offer sequencing services using Sanger method to researchers in Canada.

  6. Increasing acquisitions by key players for better penetration in the market is expected to drive the market growth. North America is expected to hold a dominant position in the global viral vector and plasmid DNA testing services market, owing to increasing acquisition by key players, which is expected to drive the North America market growth over the forecast period. For instance, in September 2016, Charles River Laboratories, Inc. acquired Agilux Laboratories, Inc. for around US$ 62.0 million. The acquisition strengthened Charles River Laboratories, Inc.’s offering for client’s drug research process. Moreover, Europe is expected to be the second dominating region in the global viral vector and plasmid DNA testing services market over the forecast period, owing to acquisitions by key players in the region. For instance, in 2017 Eurofins Scientific acquired Amatsigroup, a CDMO offering preclinical and clinical phase services for the development of human and veterinary drugs. The acquisition is expected to strengthen Eurofins position in its BioPharma services business.

  7. Key Players Major players operating in the global viral vector and plasmid DNA testing services market include Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KGaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, and Genezen Laboratories among others.

  8. Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/viral-vector-and-plasmid-dna-testing-services-market-3637

  9. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis

  10. Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  11. Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related